7,781 followers
Read Editor-in-Chief Amrita Ahluwalia's latest pick from the journal: https://t.co/BUUokFIWeS https://t.co/qRP6OrXAfY
Read Editor-in-Chief Amrita Ahluwalia's latest pick from the journal: https://t.co/BUUokFIWeS https://t.co/qRP6OrXAfY
Activation of RyR2 by class I kinase inhibitors. https://t.co/z2oH8pvK9j